S

Shanghai MicuRx Pharmaceutical Co Ltd
SSE:688373

Watchlist Manager
Shanghai MicuRx Pharmaceutical Co Ltd
SSE:688373
Watchlist
Price: 5.05 CNY -6.83% Market Closed
Market Cap: 2.2B CNY
Have any thoughts about
Shanghai MicuRx Pharmaceutical Co Ltd?
Write Note

Intrinsic Value

Shanghai MicuRx Pharmaceutical Co Ltd's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one Shanghai MicuRx Pharmaceutical Co Ltd stock under the Base Case scenario is 5.43 CNY. Compared to the current market price of 5.05 CNY, Shanghai MicuRx Pharmaceutical Co Ltd is Undervalued by 7%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
5.43 CNY
Undervaluation 7%
Intrinsic Value
Price
S
Worst Case
Base Case
Best Case

Valuation Backtest
Shanghai MicuRx Pharmaceutical Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Shanghai MicuRx Pharmaceutical Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Shanghai MicuRx Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Shanghai MicuRx Pharmaceutical Co Ltd

Provide an overview of the primary business activities
of Shanghai MicuRx Pharmaceutical Co Ltd.

What unique competitive advantages
does Shanghai MicuRx Pharmaceutical Co Ltd hold over its rivals?

What risks and challenges
does Shanghai MicuRx Pharmaceutical Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Shanghai MicuRx Pharmaceutical Co Ltd.

Provide P/S
for Shanghai MicuRx Pharmaceutical Co Ltd.

Provide P/E
for Shanghai MicuRx Pharmaceutical Co Ltd.

Provide P/OCF
for Shanghai MicuRx Pharmaceutical Co Ltd.

Provide P/FCFE
for Shanghai MicuRx Pharmaceutical Co Ltd.

Provide P/B
for Shanghai MicuRx Pharmaceutical Co Ltd.

Provide EV/S
for Shanghai MicuRx Pharmaceutical Co Ltd.

Provide EV/GP
for Shanghai MicuRx Pharmaceutical Co Ltd.

Provide EV/EBITDA
for Shanghai MicuRx Pharmaceutical Co Ltd.

Provide EV/EBIT
for Shanghai MicuRx Pharmaceutical Co Ltd.

Provide EV/OCF
for Shanghai MicuRx Pharmaceutical Co Ltd.

Provide EV/FCFF
for Shanghai MicuRx Pharmaceutical Co Ltd.

Provide EV/IC
for Shanghai MicuRx Pharmaceutical Co Ltd.

Show me price targets
for Shanghai MicuRx Pharmaceutical Co Ltd made by professional analysts.

What are the Revenue projections
for Shanghai MicuRx Pharmaceutical Co Ltd?

How accurate were the past Revenue estimates
for Shanghai MicuRx Pharmaceutical Co Ltd?

What are the Net Income projections
for Shanghai MicuRx Pharmaceutical Co Ltd?

How accurate were the past Net Income estimates
for Shanghai MicuRx Pharmaceutical Co Ltd?

What are the EPS projections
for Shanghai MicuRx Pharmaceutical Co Ltd?

How accurate were the past EPS estimates
for Shanghai MicuRx Pharmaceutical Co Ltd?

What are the EBIT projections
for Shanghai MicuRx Pharmaceutical Co Ltd?

How accurate were the past EBIT estimates
for Shanghai MicuRx Pharmaceutical Co Ltd?

Compare the revenue forecasts
for Shanghai MicuRx Pharmaceutical Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Shanghai MicuRx Pharmaceutical Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Shanghai MicuRx Pharmaceutical Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Shanghai MicuRx Pharmaceutical Co Ltd compared to its peers.

Compare the P/E ratios
of Shanghai MicuRx Pharmaceutical Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Shanghai MicuRx Pharmaceutical Co Ltd with its peers.

Analyze the financial leverage
of Shanghai MicuRx Pharmaceutical Co Ltd compared to its main competitors.

Show all profitability ratios
for Shanghai MicuRx Pharmaceutical Co Ltd.

Provide ROE
for Shanghai MicuRx Pharmaceutical Co Ltd.

Provide ROA
for Shanghai MicuRx Pharmaceutical Co Ltd.

Provide ROIC
for Shanghai MicuRx Pharmaceutical Co Ltd.

Provide ROCE
for Shanghai MicuRx Pharmaceutical Co Ltd.

Provide Gross Margin
for Shanghai MicuRx Pharmaceutical Co Ltd.

Provide Operating Margin
for Shanghai MicuRx Pharmaceutical Co Ltd.

Provide Net Margin
for Shanghai MicuRx Pharmaceutical Co Ltd.

Provide FCF Margin
for Shanghai MicuRx Pharmaceutical Co Ltd.

Show all solvency ratios
for Shanghai MicuRx Pharmaceutical Co Ltd.

Provide D/E Ratio
for Shanghai MicuRx Pharmaceutical Co Ltd.

Provide D/A Ratio
for Shanghai MicuRx Pharmaceutical Co Ltd.

Provide Interest Coverage Ratio
for Shanghai MicuRx Pharmaceutical Co Ltd.

Provide Altman Z-Score Ratio
for Shanghai MicuRx Pharmaceutical Co Ltd.

Provide Quick Ratio
for Shanghai MicuRx Pharmaceutical Co Ltd.

Provide Current Ratio
for Shanghai MicuRx Pharmaceutical Co Ltd.

Provide Cash Ratio
for Shanghai MicuRx Pharmaceutical Co Ltd.

What is the historical Revenue growth
over the last 5 years for Shanghai MicuRx Pharmaceutical Co Ltd?

What is the historical Net Income growth
over the last 5 years for Shanghai MicuRx Pharmaceutical Co Ltd?

What is the current Free Cash Flow
of Shanghai MicuRx Pharmaceutical Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Shanghai MicuRx Pharmaceutical Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Shanghai MicuRx Pharmaceutical Co Ltd

Balance Sheet Decomposition
Shanghai MicuRx Pharmaceutical Co Ltd

Current Assets 1.1B
Cash & Short-Term Investments 953.3m
Receivables 31.3m
Other Current Assets 69.6m
Non-Current Assets 114.3m
PP&E 86.2m
Intangibles 1.9m
Other Non-Current Assets 26.2m
Current Liabilities 136.6m
Accounts Payable 79.6m
Accrued Liabilities 12.9m
Other Current Liabilities 44.1m
Non-Current Liabilities 197.9m
Long-Term Debt 196.7m
Other Non-Current Liabilities 1.3m
Efficiency

Earnings Waterfall
Shanghai MicuRx Pharmaceutical Co Ltd

Revenue
81.7m CNY
Cost of Revenue
-14.9m CNY
Gross Profit
66.8m CNY
Operating Expenses
-471.1m CNY
Operating Income
-404.3m CNY
Other Expenses
6.1m CNY
Net Income
-398.1m CNY

Free Cash Flow Analysis
Shanghai MicuRx Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Shanghai MicuRx Pharmaceutical Co Ltd's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
Negative Operating Income
29/100
Profitability
Score

Shanghai MicuRx Pharmaceutical Co Ltd's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Shanghai MicuRx Pharmaceutical Co Ltd's solvency score is 71/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Long-Term Solvency
Low D/E
71/100
Solvency
Score

Shanghai MicuRx Pharmaceutical Co Ltd's solvency score is 71/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Shanghai MicuRx Pharmaceutical Co Ltd

Wall Street analysts forecast Shanghai MicuRx Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shanghai MicuRx Pharmaceutical Co Ltd is 7.01 CNY with a low forecast of 5.25 CNY and a high forecast of 8.98 CNY.

Lowest
Price Target
5.25 CNY
4% Upside
Average
Price Target
7.01 CNY
39% Upside
Highest
Price Target
8.98 CNY
78% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Shanghai MicuRx Pharmaceutical Co Ltd?

Click here to dive deeper.

Dividends

Shanghai MicuRx Pharmaceutical Co Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for Shanghai MicuRx Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Shanghai MicuRx Pharmaceutical Co Ltd

Country

China

Industry

Biotechnology

Market Cap

2.2B CNY

Dividend Yield

0%

Description

Shanghai MicuRx Pharmaceutical Co., Ltd. engages in the experimenting, discovering, and development of innovative medicines. The company is headquartered in Shanghai, Shanghai and currently employs 179 full-time employees. The company went IPO on 2022-08-05. The firm's antibacterial drug product, contezolid tablets, can be applied to treat infections caused by multidrug-resistant gram-positive bacteria. The firm also has a number of new anti-drug-resistant bacteria, kidney cancer, nephritis drugs and anti-new crown drug pipelines in the preclinical stage, including MRX-4, MRX-5, MRX-7, MRX-15, MRX-17 and others. The firm operates its businesses primarily in the domestic market.

Contact

SHANGHAI
Shanghai
Building 2, 101, 1-4F, Building 1, No. 53, Edison Road, China (Shanghai) Pilot Free Trade Zone
+862150900550
www.micurxchina.com

IPO

2022-08-05

Employees

179

Officers

CEO & Chairman
Dr. Yuan Zhengyu Ph.D.
Deputy GM, CFO, Board Secretary & Director
Mr. Zhiyue Li
Deputy GM, Senior VP & Chief Technology Officer
Mr. Xinghai Wang
Deputy GM & Chief Clinical Officer
Ms. Hong Yuan
Head of Corporate Chemistry
Mr. Liu Jingian
Head of Biological Department
Ms. Wang Wen
Show More
Deputy GM & GM of Kerui Kaisi
Mr. Dongming Zhao
Chairman of the Supervisory Board, Director of the Quality & Compliance Department
Mr. Liang Lu
Show Less

See Also

Discover More
What is the Intrinsic Value of one Shanghai MicuRx Pharmaceutical Co Ltd stock?

The intrinsic value of one Shanghai MicuRx Pharmaceutical Co Ltd stock under the Base Case scenario is 5.43 CNY.

Is Shanghai MicuRx Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 5.05 CNY, Shanghai MicuRx Pharmaceutical Co Ltd is Undervalued by 7%.

Back to Top